JP2014524888A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524888A5
JP2014524888A5 JP2014511830A JP2014511830A JP2014524888A5 JP 2014524888 A5 JP2014524888 A5 JP 2014524888A5 JP 2014511830 A JP2014511830 A JP 2014511830A JP 2014511830 A JP2014511830 A JP 2014511830A JP 2014524888 A5 JP2014524888 A5 JP 2014524888A5
Authority
JP
Japan
Prior art keywords
phenyl
alkyl
substituted
precatalyst
disproportionated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014511830A
Other languages
English (en)
Other versions
JP2014524888A (ja
JP5925301B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/059344 external-priority patent/WO2012160015A1/en
Publication of JP2014524888A publication Critical patent/JP2014524888A/ja
Publication of JP2014524888A5 publication Critical patent/JP2014524888A5/ja
Application granted granted Critical
Publication of JP5925301B2 publication Critical patent/JP5925301B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

従って、ルテニウム核、4個の中程度に結合された配位子(L)(例えば、CO、CN又はCOD)及びH、(C1−C6)アルキル又はフェニル(式中、フェニルは、ハロゲン、好ましくはF又はClによって、1回又はそれ以上、好ましくは1〜3回、場合により置換されている)よ
り互いに独立して選択される4個の置換基Zで場合により置換されているシクロペンタジエン配位子、及びOH/=O、NHR5/C=NR5(式中、R5は、(C1−C6)アルキル、フェニル、又はベンジルである)、又はSH/=S、のような酸化対(UH/U)を有する基を有する、その二量体プレ触媒形態(式2)及びその不均化形態(式2a及び2b)で下記に記載のShvo触媒又は
その誘導体は、選択的H/D交換を開始するために同一の様式で機能すると考えられる:
Figure 2014524888
JP2014511830A 2011-05-23 2012-05-21 N−アルキル基を含有するジュウテリウム化化合物の製造方法 Expired - Fee Related JP5925301B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11305634 2011-05-23
EP11305634.5 2011-05-23
PCT/EP2012/059344 WO2012160015A1 (en) 2011-05-23 2012-05-21 Process for the preparation of deuterated compounds containing n-alkyl groups

Publications (3)

Publication Number Publication Date
JP2014524888A JP2014524888A (ja) 2014-09-25
JP2014524888A5 true JP2014524888A5 (ja) 2015-07-02
JP5925301B2 JP5925301B2 (ja) 2016-05-25

Family

ID=46146876

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014511830A Expired - Fee Related JP5925301B2 (ja) 2011-05-23 2012-05-21 N−アルキル基を含有するジュウテリウム化化合物の製造方法

Country Status (10)

Country Link
US (1) US9340489B2 (ja)
EP (1) EP2714624B1 (ja)
JP (1) JP5925301B2 (ja)
KR (1) KR20140030267A (ja)
CN (1) CN103702961A (ja)
CA (1) CA2834920A1 (ja)
IL (1) IL229037A0 (ja)
RU (1) RU2013156864A (ja)
SG (1) SG194625A1 (ja)
WO (1) WO2012160015A1 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016028119A2 (pt) 2014-06-06 2017-08-22 Res Triangle Inst Agonistas receptores de apelina (apj) e usos dos mesmos
MX2017006043A (es) * 2014-11-10 2018-02-13 Forge Life Science Llc Metodo y composiciones de anti-hcmv.
EP3386976A1 (en) 2015-12-09 2018-10-17 Research Triangle Institute, International Improved apelin receptor (apj) agonists and uses thereof
AU2017325870B2 (en) 2016-09-16 2021-07-22 Research Traingle Institute Tetrahydroisoquinoline kappa opioid antagonists
MX2019004214A (es) 2016-10-12 2019-06-10 Res Triangle Inst Agonistas heterociclicos del receptor de apelina (apj) y usos de los mismos.
JOP20190072A1 (ar) 2016-10-13 2019-04-07 Glaxosmithkline Ip Dev Ltd مشتقات 1، 3 سيكلوبوتان ثنائي الاستبدال أو آزيتيدين كمثبطات للإنزيم المخلق للبروستاجلاندين d المكون للدم
CA3036382A1 (en) 2016-12-21 2018-06-28 Research Triangle Institute Diaryl purine derivatives with improved bioavailability
KR20200004827A (ko) 2017-04-27 2020-01-14 듀테리아 비버리지스, 엘엘씨 D2로부터 중수소화 에탄올을 제조하는 방법
EA039504B1 (ru) * 2017-04-27 2022-02-03 Дьютерия Бевериджес, Ллс Способ получения дейтерированного этанола из d2o
BR112020003725A2 (pt) 2017-10-06 2020-11-03 Forma Therapeutics, Inc. inibição da peptidase 30 específica de ubiquitina
CN109748767A (zh) * 2017-11-07 2019-05-14 朱允涛 一种利用微波反应装置制备氘代胺类化合物的方法
JP7449242B2 (ja) 2018-05-17 2024-03-13 フォーマ セラピューティクス,インコーポレイテッド ユビキチン特異的ペプチダーゼ30(usp30)阻害剤として有用な縮合二環化合物
SI3860989T1 (sl) 2018-10-05 2023-06-30 Forma Therapeutics, Inc. Kondenzirani pirolini,ki delujejo kot zaviralci ubikvitin-specifične proteaze (usp30)
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
CA3124399A1 (en) * 2018-12-21 2020-06-25 Concert Pharmaceuticals, Inc. Deuterated forms and derivatives of volinanserin
MX2023007793A (es) 2020-12-30 2023-09-22 Tyra Biosciences Inc Compuestos de indazol como inhibidores de cinasas.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
EP0335918A1 (en) 1987-08-07 1989-10-11 Mallinckrodt Diagnostica (Holland) B.V. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
US5075337A (en) 1989-07-26 1991-12-24 G. D. Searle & Co. Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
DE69105501T2 (de) 1990-06-01 1995-04-13 Merrell Dow Pharma (+)-alpha-(2,3 dimethoxyphenyl)-1-[2-(fluorophenyl)ethyl]-4-piperidinmethanol.
KR20040068613A (ko) 1994-03-25 2004-07-31 이소테크니카 인코포레이티드 중수소화된 화합물 이를 포함하는 고혈압 치료용 조성물
EP1688412A3 (en) 2001-02-16 2006-08-16 Aventis Pharmaceuticals, Inc. Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
TW200413273A (en) 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
TW200413274A (en) * 2002-12-27 2004-08-01 Wako Pure Chem Ind Ltd Deuteration or tritiation method
CA2553376A1 (en) 2004-01-23 2005-08-04 Wako Pure Chemical Industries, Ltd. Method of deuteration using mixed catalyst
WO2008122010A1 (en) 2007-04-02 2008-10-09 Concert Pharmaceuticals, Inc. Pharmaceutical calcimimetics
WO2009005069A1 (ja) 2007-07-05 2009-01-08 Wako Pure Chemical Industries, Ltd. ルテニウム触媒を用いた重水素化方法
US20100143287A1 (en) 2008-12-09 2010-06-10 Auspex Pharmaceuticals, Inc. Trifluoromethylphenyl modulators of calcium-sensing receptor

Similar Documents

Publication Publication Date Title
JP2014524888A5 (ja)
JP2013040159A5 (ja) 有機金属錯体
JP2013147496A5 (ja) 有機金属錯体
JP2014029971A5 (ja) 有機化合物
JP2013102146A5 (ja) 化合物
JP2013010749A5 (ja) カルバゾール化合物
JP2015042636A5 (ja) 有機化合物
JP2012140458A5 (ja)
JP2013010752A5 (ja) 有機金属錯体
JP2013126982A5 (ja) 有機金属錯体及び発光材料
JP2012149030A5 (ja) 化合物
JP2012248871A5 (ja) 発光素子および発光装置
JP2014158032A5 (ja)
JP2012092103A5 (ja)
JP2010241801A5 (ja)
JP2013100341A5 (ja)
JP2012006912A5 (ja) トリアゾール誘導体
JP2011121940A5 (ja) 発光素子
JP2015078176A5 (ja)
JP2010189376A5 (ja) 有機金属錯体
JP2013010096A5 (ja)
JP2011105738A5 (ja)
JP2012140436A5 (ja) 物質
JP2013147490A5 (ja) イリジウム錯体
JP2013010730A5 (ja) フルオレン化合物および有機化合物